eMedicine Specialties > Ophthalmology > Dermatologic Disorders

Ichthyosis

Author: Kenneth M Goins, MD, Professor of Clinical Ophthalmology, Director of Cornea and External Diseases and Refractive Surgery, Department of Ophthalmology, University of Iowa Hospitals and Clinics; Medical Director of Iowa Lions Eye Bank
Coauthor(s): Seth Adam Anderson, Des Moines University College of Osteopathic Medicine
Contributor Information and Disclosures

Updated: Dec 12, 2007

Introduction

Background

Ichthyosis refers to a relatively uncommon group of skin disorders characterized by the presence of excessive amounts of dry surface scales. It is regarded as a disorder of keratinization or cornification, and it is due to abnormal epidermal differentiation or metabolism.

The ichthyosiform dermatoses may be classified according to clinical manifestations, genetic presentation, and histologic findings. Inherited and acquired forms of ichthyosis have been described, and ocular alterations may occur in specific subtypes. Five distinct types of inherited ichthyosis exist, as follows: ichthyosis vulgaris, lamellar ichthyosis, epidermolytic hyperkeratosis, congenital ichthyosiform erythroderma, and X-linked ichthyosis.

Pathophysiology

In ichthyosis vulgaris, dry skin and follicular accentuation (keratosis pilaris) usually appear at puberty. Scaling is most prominent over the trunk, abdomen, buttocks, and legs. The flexural areas, such as the antecubital fossa, are spared. An association may be present between ichthyosis vulgaris and atopic diseases because one third to one half of patients show features of atopic disease and a similar proportion have relatives with atopic disease. A reported 11.5% association exists between atopic dermatitis and primary hereditary ichthyosis. Ichthyosis vulgaris typically produces no significant ocular findings; however, scaling may be present on the eyelid skin, which could lead to punctate epithelial keratitis and recurrent corneal erosion. Linkage analysis has identified an ichthyosis vulgaris locus on band 1q22.

Two loss-of-function mutations in the coding of the filaggrin gene have been identified in both ichthyosis vulgaris and atopic dermatitis. Keratohyalin synthesis is affected because of the filaggrin mutation. Filaggrin is an epidermal protein that normally functions as a barrier molecule against environmental allergens, water loss, and infection.

In epidermolytic hyperkeratosis, the skin is moist, red, and tender at birth. Bullae formation may occur, which may become infected and give rise to a foul skin odor. Thick, generalized, verrucous scaling occurs within a few days. Localized scaling may be seen, especially in the flexural creases. A mutation in the keratin genes (ie, KRT1, KRT10) is the cause of this autosomal dominant disorder.

Lamellar ichthyosis is a rare, autosomal recessive, genetically heterogeneous skin disease caused by mutations involving multiple genetic loci. Type 1 maps to band 14q11.2 and is caused by mutations in the gene for keratinocyte transglutaminase 1, an enzyme responsible for the assembly of the keratinized envelope. Type 2, which is clinically indistinguishable from type 1, maps to band 2q33-q35. In classic lamellar ichthyosis, children with the disease are referred to as collodion babies and are covered at birth by a thickened membrane that subsequently is shed. The scaling of the skin involves the whole body with no sparing of the flexural creases. Approximately one third of children affected with this disorder develop bilateral ectropion of the cicatricial type that appears to result from excessive dryness of the skin and subsequent contracture. Secondary corneal ulceration may occur secondary to long-term exposure.

In X-linked ichthyosis, generalized scaling is present at or shortly after birth. This scaling is most prominent over the extremities, neck, trunk, and buttocks. The flexural creases, palms, and soles are spared. Irregular stromal corneal opacities that are located anterior to the Descemet membrane are found in 16-50% of male patients, and this finding may be used to distinguish this form of ichthyosis from all other forms. Approximately 25% of female carriers have minor corneal opacities. The corneal opacities are not known to affect visual acuity. 

Previous studies have shown a deficiency of steroid sulfatase (STS) in skin fibroblasts and a marked elevation of plasma cholesterol sulfate in patients with X-linked ichthyosis. In most cases, STS deficiency is caused by a partial or complete deletion of the STS gene mapped on band Xp22.3. Deletions of the STS gene have systemic effects, such as corneal opacities, cryptorchidism, and failed progression during labor. Deletions to flank regions of the STS gene have been linked with mental retardation. These deletions involve portions of the VCXA and VCXB1 genes.

Congenital ichthyosiform erythroderma (CIE) is a milder form of the disease that is autosomal recessive in inheritance. CIE has been found to be caused by mutations in the genes coding for transglutaminase 1, 12R-lipoxygenase, and/or lipoxygenase 3. The lipoxygenase genes play a role in the epidermal permeability layer. As with lamellar ichthyosis, neonates with CIE are referred to as collodion babies, but, as children and adults, they show generalized red skin with thin, white scaling. Other manifestations include persistent ectropion and scarring alopecia.

Multiple congenital ectodermal dysplastic syndromes are associated with scaling and other system defects. The keratitis, ichthyosis, and deafness (KID) syndrome is a congenital disorder of ectoderm that affects not only the epidermis but also other ectodermal tissues, such as the corneal epithelium and the inner ear. KID syndrome may present with the Hutchinson triad (the combination of notched, widely spaced peg teeth, interstitial keratitis, and deafness). KID syndrome has been linked to mutations in the connexin 26 gene (GJB2) on band 13q11-q12.

The colobomas of the eye, heart defects, ichthyosiform dermatosis, mental retardation, and ear defects (CHIME) syndrome comprise a rare neuroectodermal disorder.

Netherton syndrome is an autosomal recessive condition that consists of an ichthyosiform dermatosis with variable erythroderma, hair shaft defects, and atopic features. Netherton syndrome has been linked to a mutation on band 5q32, specifically encoding for LEKTI (lymphoepithelial Kazal-type—related inhibitor), a serine protease inhibitor. 

Sjögren-Larsson syndrome is an autosomal recessive condition that comprises ichthyosis, spastic diplegia, pigmentary retinopathy, and mental retardation.

Congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD) syndrome is a rare X-linked dominant malformation syndrome characterized by unilaterally distributed ichthyosiform nevi, often sharply delimited at the midline, and ipsilateral limb defects. This syndrome is caused by a loss-of-function mutation of NSDHL (NAD(P)H steroid dehydrogenase-like protein) at band Xq28.

Darier-White disease or keratosis follicularis is an autosomal dominant disorder in which there is a loss of adhesion between epidermal keratinocytes and abnormal keratinization. It is caused by mutations in genes coding for the endoplasmic reticulum Ca(+2)-ATPase (ATP2A2). Exposure to UVB light can exacerbate the skin lesions found in Darier-White disease.

Acquired ichthyosis usually occurs in adults and manifests as small, white, fishlike scales that frequently are concentrated on the extremities but may be seen in a generalized distribution. This form of ichthyosis may be associated with internal neoplasia (eg, Hodgkin lymphoma, leukemia), systemic illness (eg, sarcoidosis, HIV infection, hypothyroidism, chronic hepatitis, malabsorption), bone marrow transplantation, or the intake of certain medications that interfere with sterol synthesis in epidermal cells (eg, nicotinic acid). Newborns with type 2 Gaucher disease (glucosyl cerebroside lipidosis) may present with ichthyotic skin at birth prior to neurologic manifestations, which could be mistaken for a congenital form of ichthyosis.

Frequency

United States

Ichthyosis vulgaris is the most common form and is an autosomal dominant trait with an incidence of 1 in 300.

Epidermolytic hyperkeratosis is an autosomal dominant disorder with an incidence of 1 in 300,000 in the general population.

Lamellar ichthyosis, a more severe form of dermatosis, is an autosomal recessive trait with an incidence of 1 in 300,000.

X-linked recessive ichthyosis has an incidence of 1 in 6000 in male patients.

International

Studies show that a higher prevalence of X-linked ichthyosis as compared to ichthyosis vulgaris may exist in Mexico, which is markedly different from the experience in the United States.

In the United Kingdom, the incidence of ichthyosis vulgaris was reported to be 1 in 250, in a study population of 6501 healthy school children. Similarly, in another large epidemiological study, the incidence of X-linked recessive ichthyosis was 1 in 6190 males.

In a Danish population study, the predicted incidence of X-linked recessive ichthyosis was 1 in 2000 males.

In southern coastal Italy, the frequency of X-linked recessive ichthyosis was estimated at 1.98 in 10,000 males.

In China, ichthyosis vulgaris has a prevalence of 2.29%.

Mortality/Morbidity

  • An increased risk of testicular cancer in men with ichthyosis vulgaris has been suggested.
  • In addition, an increased incidence of testicular maldescent, cryptorchidism, abnormalities of the sperm count or motility leading to infertility, and testicular cancer has been reported in patients with X-linked recessive ichthyosis.

Race

In general, all races may be affected in the inherited and acquired forms of ichthyosis.

Sex

X-linked recessive ichthyosis is much more prevalent in males. It is caused by a deficiency of STS. Because this enzyme plays an important role in androgen metabolism, it is hypothesized that men with this ailment do not show androgenetic alopecia or develop only mild forms of this common type of hair loss.

Clinical

History

See Pathophysiology.

Physical

Ocular and periocular manifestations that may be seen in the ichthyosiform syndromes include the following:

  • Conjunctiva - Keratinization and thickening secondary to ectropion
  • Cornea
    • Exposure keratitis secondary to ectropion
    • Unilateral megalocornea (lamellar ichthyosis)
    • Pre-Descemet membrane opacities (X-linked ichthyosis)
    • Recurrent corneal erosion
    • Band keratopathy
    • Salzmann nodules (ichthyosis vulgaris)
    • Microphthalmos (rare)
    • Anterior chamber cleavage syndrome (rare)
    • Enlarged corneal nerves (common to all forms)
    • Stromal vascularization
    • Limbal stem cell deficiency (KID syndrome [common])
  • Eyelids
    • Ectropion (lamellar ichthyosis)
    • Blepharitis
    • Meibomian gland absence (rare)
    • Trichiasis
    • Madarosis
    • Lacrimal puncta absence
  • Retina
    • Coloboma (CHIME syndrome)
    • Retinitis pigmentosa (Refsum disease)
    • Maculopathy (Sjögren-Larsson syndrome)
    • Tortuous vessels (carrier state in ichthyosis follicularis-alopecia-photophobia [IFAP] syndrome)

Causes

See Pathophysiology.

More on Ichthyosis

Overview: Ichthyosis
Differential Diagnoses & Workup: Ichthyosis
Treatment & Medication: Ichthyosis
Follow-up: Ichthyosis
Multimedia: Ichthyosis
References

References

  1. Akiyama M, Suzumori K, Shimizu H. Prenatal diagnosis of harlequin ichthyosis by the examination of keratinized hair canals and amniotic fluid cells at 19 weeks' estimated gestational age. Prenat Diagn. Feb 1999;19(2):167-71. [Medline].

  2. Al-Akloby OM. Association of atopic dermatitis with primary hereditary ichthyoses. Saudi Med J. Aug 2004;25(8):1097-9. [Medline].

  3. Baden HP, Imber M. Ichthyosis with an unusual constellation of ectodermal dysplasias. Clin Genet. Jun 1989;35(6):455-61. [Medline].

  4. Bale SJ, DiGiovanna JJ. Genetic approaches to understanding the keratinopathies. Adv Dermatol. 1997;12:99-113; discussion 114. [Medline].

  5. Banse-Kupin L, Pelachyk JM. Ichthyosiform sarcoidosis. Report of two cases and a review of the literature. J Am Acad Dermatol. Oct 1987;17(4):616-20. [Medline].

  6. Bitoun E, Chavanas S, Irvine AD, Lonie L, Bodemer C, Paradisi M. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol. Feb 2002;118(2):352-61. [Medline].

  7. Caceres-Rios H, Tamayo-Sanchez L, Duran-Mckinster C, de la Luz Orozco M, Ruiz-Maldonado R. Keratitis, ichthyosis, and deafness (KID syndrome): review of the literature and proposal of a new terminology. Pediatr Dermatol. Mar-Apr 1996;13(2):105-13. [Medline].

  8. Casaroli Marano RP, Ortiz Stradtmann MA, Uxo M, Iglesias E. Ocular findings associated with congenital X-linked ichthyosis. Ann Ophthalmol. May 1991;23(5):167-72. [Medline].

  9. Chiaretti A, Schembri Wismayer D, Tortorolo L, Piastra M, Polidori G. Salicylate intoxication using a skin ointment. Acta Paediatr. Mar 1997;86(3):330-1. [Medline].

  10. Costagliola C, Fabbrocini G, Illiano GM, Scibelli G, Delfino M. Ocular findings in X-linked ichthyosis: a survey on 38 cases. Ophthalmologica. 1991;202(3):152-5. [Medline].

  11. Cuevas-Covarrubias SA, Diaz-Zagoya JC, Rivera-Vega MR, Beirana A, Carrasco E, Orozco E, et al. Higher prevalence of X-linked ichthyosis vs. ichthyosis vulgaris in Mexico. Int J Dermatol. Jul 1999;38(7):555-6. [Medline].

  12. Culican SM, Custer PL. Repair of cicatricial ectropion in an infant with harlequin ichthyosis using engineered human skin. Am J Ophthalmol. Sep 2002;134(3):442-3. [Medline].

  13. Derse M, Wannke E, Payer H, Rohrbach JM, Zierhut M. [Successful topical cyclosporin A in the therapy of progressive vascularising keratitis in keratitis-ichthyosis-deafness (KID) syndrome (Senter syndrome)]. Klin Monatsbl Augenheilkd. May 2002;219(5):383-6. [Medline].

  14. Dilek I, Demirer T, Ustün C, Arat M, Koç H, Beksac M, et al. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. Bone Marrow Transplant. Jun 1998;21(11):1159-61. [Medline].

  15. Gicquel JJ, Lami MC, Catier A, Balayre S, Dighiero P. [Limbal stem cell deficiency associated with KID syndrome, about a case]. J Fr Ophtalmol. Dec 2002;25(10):1061-4. [Medline].

  16. Gloerich J, Ijlst L, Wanders RJ, Ferdinandusse S. Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome. Mol Genet Metab. Sep-Oct 2006;89(1-2):111-5. [Medline].

  17. Happle R, Hoffmann R. Absence of male-pattern baldness in men with X-linked recessive ichthyosis? A hypothesis to be challenged. Dermatology. 1999;198(3):231-2. [Medline].

  18. Hazan C, Orlow SJ, Schaffer JV. X-linked recessive ichthyosis. Dermatol Online J. 2005;11(4):12. [Medline].

  19. Hoffjan S, Stemmler S. On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis. Br J Dermatol. Sep 2007;157(3):441-9. [Medline].

  20. Hosomi N, Oiso N, Fukai K, Hanada K, Fujita H, Ishii M. Deletion of distal promoter of VCXA in a patient with X-linked ichthyosis associated with borderline mental retardation. J Dermatol Sci. Jan 2007;45(1):31-6. [Medline].

  21. Hummel M, Cunningham D, Mullett CJ, Kelley RI, Herman GE. Left-sided CHILD syndrome caused by a nonsense mutation in the NSDHL gene. Am J Med Genet A. Oct 15 2003;122(3):246-51. [Medline].

  22. Ingordo V, D'Andria G, Gentile C, Decuzzi M, Mascia E, Naldi L. Frequency of X-linked ichthyosis in coastal southern Italy: a study on a representative sample of a young male population. Dermatology. 2003;207(2):148-50. [Medline].

  23. Kaplan MH, Sadick NS, McNutt NS, Talmor M, Coronesi M, Hall WW. Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse. J Am Acad Dermatol. Nov 1993;29(5 Pt 1):701-8. [Medline].

  24. Kawashima J, Akiyama M, Takizawa Y, Takahashi S, Matsuo I, Shimizu H. Structural, enzymatic and molecular studies in a series of nonbullous congenital ichthyosiform erythroderma patients. Clin Exp Dermatol. Jul 2005;30(4):429-31. [Medline].

  25. König A, Happle R, Bornholdt D, Engel H, Grzeschik KH. Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet. Feb 14 2000;90(4):339-46. [Medline].

  26. Küster W, Bohnsack K, Rippke F, Upmeyer HJ, Groll S, Traupe H, et al. Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology. 1998;196(2):217-22. [Medline].

  27. Lacz NL, Schwartz RA, Kihiczak G. Epidermolytic hyperkeratosis: a keratin 1 or 10 mutational event. Int J Dermatol. Jan 2005;44(1):1-6. [Medline].

  28. Lee HW, Ahn SJ, Choi JC, Chang SE, Choi JH, Moon KC, et al. Acquired ichthyosis associated with an overlap syndrome of systemic sclerosis and systemic lupus erythematosus. J Dermatol. Jan 2006;33(1):52-4. [Medline].

  29. Leung PC, Ma GF. Ectropion of all four eyelids associated with severe ichthyosis congenita: a case report. Br J Plast Surg. Jul 1981;34(3):302-4. [Medline].

  30. Lucker GP, Heremans AM, Boegheim PJ, van de Kerkhof PC, Steijlen PM. Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole. Br J Dermatol. Jan 1997;136(1):71-5. [Medline].

  31. Marulli GC, Campione E, Chimenti MS, Terrinoni A, Melino G, Bianchi L. Type I lamellar ichthyosis improved by tazarotene 0.1% gel. Clin Exp Dermatol. Jul 2003;28(4):391-3. [Medline].

  32. Mayuzumi N, Ikeda S, Kawada H, Ogawa H. Effects of drugs and anticytokine antibodies on expression of ATP2A2 and ATP2C1 in cultured normal human keratinocytes. Br J Dermatol. May 2005;152(5):920-4. [Medline].

  33. Messmer EM, Kenyon KR, Rittinger O, Janecke AR, Kampik A. Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome. Ophthalmology. Feb 2005;112(2):e1-6. [Medline].

  34. Montague I, Fox R, Mann R. Intra-amniotic debris identified at ultrasound scanning: a feature of congenital ichthyosis. Ultrasound Obstet Gynecol. May 1997;9(5):350-1. [Medline].

  35. Moran JL, Qiu H, Turbe-Doan A, Yun Y, Boeglin WE, Brash AR, et al. A mouse mutation in the 12R-lipoxygenase, Alox12b, disrupts formation of the epidermal permeability barrier. J Invest Dermatol. Aug 2007;127(8):1893-7. [Medline].

  36. Moskowitz DG, Fowler AJ, Heyman MB, Cohen SP, Crumrine D, Elias PM, et al. Pathophysiologic basis for growth failure in children with ichthyosis: an evaluation of cutaneous ultrastructure, epidermal permeability barrier function, and energy expenditure. J Pediatr. Jul 2004;145(1):82-92. [Medline].

  37. Oji V, Beljan G, Beier K, Traupe H, Luger TA. Topical pimecrolimus: a novel therapeutic option for Netherton syndrome. Br J Dermatol. Nov 2005;153(5):1067-8. [Medline].

  38. Orth DH, Fretzin DF, Abramson V. Collodion baby with transient bilateral upper lid ectropion. Review of ocular manifestations in ichthyosis. Arch Ophthalmol. Mar 1974;91(3):206-7. [Medline].

  39. Pagliaro JA, White SI. Specific skin lesions occurring in a patient with Hodgkin's lymphoma. Australas J Dermatol. Feb 1999;40(1):41-3. [Medline].

  40. Patel N, Spencer LA, English JC 3rd, Zirwas MJ. Acquired ichthyosis. J Am Acad Dermatol. Oct 2006;55(4):647-56. [Medline].

  41. Richard G, Rouan F, Willoughby CE, Brown N, Chung P, Ryynanen M, et al. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet. May 2002;70(5):1341-8. [Medline].

  42. Sarici SU, Sahin M, Yurdakök M. Topical N-acetylcysteine treatment in neonatal ichthyosis. Turk J Pediatr. Jul-Sep 2003;45(3):245-7. [Medline].

  43. Schnur RE, Greenbaum BH, Heymann WR, Christensen K, Buck AS, Reid CS, et al. Acute lymphoblastic leukemia in a child with the CHIME neuroectodermal dysplasia syndrome. Am J Med Genet. Oct 3 1997;72(1):24-9. [Medline].

  44. Schorderet DF, Huber M, Laurini RN, Von Moos G, Gianadda B, Deleze G, et al. Prenatal diagnosis of lamellar ichthyosis by direct mutational analysis of the keratinocyte transglutaminase gene. Prenat Diagn. May 1997;17(5):483-6. [Medline].

  45. Shwayder T. Disorders of keratinization: diagnosis and management. Am J Clin Dermatol. 2004;5(1):17-29. [Medline].

  46. Sun JD, Linden KG. Netherton syndrome: a case report and review of the literature. Int J Dermatol. Jun 2006;45(6):693-7. [Medline].

  47. Suresh S, Vijayalakshmi R, Indrani S, Lata M. Short foot length: a diagnostic pointer for harlequin ichthyosis. J Ultrasound Med. Dec 2004;23(12):1653-7. [Medline].

  48. Takechi K, Sekiguchi K, Goto S. [A case of keratitis, ichthyosis, and deafness syndrome with Hutchinson's triad-like symptoms]. Nippon Ganka Gakkai Zasshi. Apr 1999;103(4):322-6. [Medline].

  49. Thiers BH. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis. J Am Acad Dermatol. Sep 1997;37(3 Pt 2):S69-71. [Medline].

  50. Traboulsi E, Waked N, Megarbane H. Ocular findings in ichthyosis follicularis-alopecia-photophobia (IFAP) syndrome. Ophthalmic Genet. Jun 2004;25(2):153-6. [Medline].

  51. Tsochatzis E, Vassilopoulos D, Deutsch M, Asvesti C, Sevastos N, Archimandritis AJ. Myelodysplastic syndrome presenting as acquired ichthyosis. Eur J Intern Med. Aug 2006;17(5):368-9. [Medline].

  52. Zhong W, Cui B, Zhang Y, Jiang H, Wei S, Bu L, et al. Linkage analysis suggests a locus of ichthyosis vulgaris on 1q22. J Hum Genet. 2003;48(7):390-2. [Medline].

Further Reading

Keywords

ichthyosis vulgaris, lamellar ichthyosis, epidermolytic hyperkeratosis, X-linked ichthyosis, acquired ichthyosis

Contributor Information and Disclosures

Author

Kenneth M Goins, MD, Professor of Clinical Ophthalmology, Director of Cornea and External Diseases and Refractive Surgery, Department of Ophthalmology, University of Iowa Hospitals and Clinics; Medical Director of Iowa Lions Eye Bank
Kenneth M Goins, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Cataract and Refractive Surgery, Eye Bank Association of America, International Society of Refractive Surgery, and Iowa Medical Society
Disclosure: Nothing to disclose.

Coauthor(s)

Seth Adam Anderson, Des Moines University College of Osteopathic Medicine
Disclosure: Nothing to disclose.

Medical Editor

Andrew A Dahl, MD, Director of Ophthalmology Teaching, Mid-Hudson Family Practice Institute, The Institute for Family Health; Assistant Professor of Surgery (Ophthalmology), New York College of Medicine
Andrew A Dahl, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American College of Surgeons, American Medical Association, American Society of Cataract and Refractive Surgery, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Mark T Duffy, MD, PhD, Consulting Staff, Division of Oculoplastic, Orbito-facial, Lacrimal and Reconstructive Surgery, Green Bay Eye Clinic, BayCare Clinic; Medical Director, Advanced Cosmetic Solutions, A BayCare Clinic
Mark T Duffy, MD, PhD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Ophthalmic Plastic and Reconstructive Surgery, Sigma Xi, and Society for Neuroscience
Disclosure: Allergan - Botox Cosmetic Consulting fee Consulting; Quest medical - lacrimal balloons Honoraria Speaking and teaching; Ortho-Neutrogenia Consulting fee Consulting

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.